Structured products
Locked out of longevity
Despite regulatory scrutiny of life settlement products and concerns over the complexity of assessing longevity risk, the institutional structured product market in the asset class is growing exponentially. But will these products ever be suitable for…
Counting the cost of counterparty risk
A few years ago no-one worried about counterparty credit risk. Then a year ago that was all anyone cared about. As markets begin to settle down, the shake-up could have longer-term implications for the structured products market. By John Ferry
Market snapshot
Tim Mortimer of Future Value Consultants looks at the pricing issues for structured products in different markets and provides his trade of the month
